| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dare Bioscience, Inc. (DARE) has 6 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. DARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 57.0K | $165.9K | - | |
| Dir | 4.5K | $13.1K | - | |
| Dir | 4.5K | $13.1K | - | |
| Dir | 4.5K | $13.1K | - | |
| Dir | 4.5K | $13.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2019 | Hawley Roger | Director | Buy | 454,545 | $1.10 | $499,999.50 | +92.7% | |
| Jun 11, 2018 | Hawley Roger | Director | Buy | 140,000 | $1.45 | $203,378.00 | New | |
| Feb 22, 2016 | Walt David R54 | Director | Buy | 2,291 | $2.08 | $4,763.22 | +0.7% | |
| Feb 18, 2016 | Walt David R54 | Director | Buy | 8,960 | $2.10 | $18,841.88 | +2.8% | |
| Feb 16, 2016 | Walt David R54 | Director | Buy | 8,811 | $2.00 | $17,645.43 | +2.9% | |
| Feb 11, 2016 | Walt David R54 | Director | Buy | 8,850 | $2.05 | $18,171.98 | +3.1% | |
| Feb 9, 2016 | Walt David R54 | Director | Buy | 9,000 | $2.15 | $19,317.60 | +3.4% | |
| Feb 5, 2016 | Walt David R54 | Director | Buy | 8,563 | $2.30 | $19,705.90 | +3.5% | |
| Feb 3, 2016 | Walt David R54 | Director | Buy | 8,413 | $2.32 | $19,540.02 | +3.7% | |
| Feb 1, 2016 | Walt David R54 | Director | Buy | 5,700 | $2.38 | $13,550.10 | +2.7% |